CLINICAL_TRIALS
trial_result
· 2018-07-23
Clinical Trial Update: Lanreotide Autogel and Pegvisomant Combination Therapy in Acromegalic Patients [Phase 3]
Summary
Phase 3 clinical trial evaluating combination therapy with lanreotide Autogel and pegvisomant in acromegaly has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Ipsen | Conditions: Acromegaly | Phase 3 | Status: COMPLETED | Results posted: 2018-07-23